Veradermics, Inc.
VDPHL01
pattern hair loss
Resolved
71days ago
Phase 2 readout · Apr 27, 2026
What's at stake
Phase 2 trial results for VDPHL01 in pattern hair loss are due Apr 27, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 16h ago
“Veradermics announced positive topline results from Part A of its randomized, double-blind, placebo-controlled Phase 2/3 clinical trial (Study ‘302’) evaluating VDPHL01, a proprietary extended-release oral minoxidil formulation, in over 500”